title: Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain.
abstract: Though cerebral white matter injury is a frequently described phenomenon in aging and dementia, the cause of white matter lesions has not been conclusively determined. Since the lesions are often associated with cerebrovascular risk factors, ischemia emerges as a potential condition for the development of white matter injury. In the present study, we induced experimental cerebral hypoperfusion by permanent, bilateral occlusion of the common carotid arteries of rats (n=6). A sham-operated group served as control (n=6). Thirteen weeks after the onset of occlusion, markers for astrocytes, microglia, and myelin were found to be labeled by means of immunocytochemistry in the corpus callosum, the internal capsule, and the optic tract. The ultrastructural integrity and oligodendrocyte density in the optic tract were investigated by electron microscopy. Quantitative analysis revealed that chronic cerebral hypoperfusion caused mild astrogliosis in the corpus callosum and the internal capsule, while astrocytic disintegration in the optic tract increased by 50%. Further, a ten-fold increase in microglial activation and a nearly doubled oligodendrocyte density were measured in the optic tract of the hypoperfused rats as compared with the controls. Finally, vacuolization and irregular myelin sheaths were observed at the ultrastructural level in the optic tract. In summary, the rat optic tract appears to be particularly vulnerable to ischemia, probably because of the rat brain's angioarchitecture. Since the detected glial changes correspond with those reported in vascular and Alzheimer dementia, this model of cerebral hypoperfusion may serve to characterize the causal relationship between ischemia and white matter damage.
authors.affiliation: Department of Molecular Neurobiology, University of Groningen, The Netherlands. farkase@anat-fm.szote.u-szeged.hu
authors.forename: Eszter
authors.initials: E
authors.lastname: Farkas
authors.forename: Gergely
authors.initials: G
authors.lastname: Donka
authors.forename: Rob A I
authors.initials: RA
authors.lastname: de Vos
authors.forename: András
authors.initials: A
authors.lastname: Mihály
authors.forename: Ferenc
authors.initials: F
authors.lastname: Bari
authors.forename: Paul G M
authors.initials: PG
authors.lastname: Luiten
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000473:pathology* / Q000648:ultrastructure; D039481:CD11b Antigen / Q000378:metabolism; D002340:Carotid Artery Diseases / Q000150:complications; D017536:Carotid Artery, Common; D002452:Cell Count / Q000379:methods; D003250:Constriction; D004195:Disease Models, Animal; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D020925:Hypoxia-Ischemia, Brain / Q000378:metabolism / Q000473:pathology*; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D008854:Microscopy, Electron / Q000379:methods; D004676:Myelin Basic Protein / Q000378:metabolism; D009413:Nerve Fibers, Myelinated / Q000473:pathology / Q000648:ultrastructure; D009457:Neuroglia / Q000378:metabolism* / Q000648:ultrastructure; D051381:Rats; D017208:Rats, Wistar
chemical_list: D039481:CD11b Antigen; D005904:Glial Fibrillary Acidic Protein; D004676:Myelin Basic Protein